Measuring inconsistency in meta-analyses
Reads0
Chats0
TLDR
A new quantity is developed, I 2, which the authors believe gives a better measure of the consistency between trials in a meta-analysis, which is susceptible to the number of trials included in the meta- analysis.Abstract:
Cochrane Reviews have recently started including the quantity I 2 to help readers assess the consistency of the results of studies in meta-analyses. What does this new quantity mean, and why is assessment of heterogeneity so important to clinical practice?
Systematic reviews and meta-analyses can provide convincing and reliable evidence relevant to many aspects of medicine and health care.1 Their value is especially clear when the results of the studies they include show clinically important effects of similar magnitude. However, the conclusions are less clear when the included studies have differing results. In an attempt to establish whether studies are consistent, reports of meta-analyses commonly present a statistical test of heterogeneity. The test seeks to determine whether there are genuine differences underlying the results of the studies (heterogeneity), or whether the variation in findings is compatible with chance alone (homogeneity). However, the test is susceptible to the number of trials included in the meta-analysis. We have developed a new quantity, I 2, which we believe gives a better measure of the consistency between trials in a meta-analysis.
Assessment of the consistency of effects across studies is an essential part of meta-analysis. Unless we know how consistent the results of studies are, we cannot determine the generalisability of the findings of the meta-analysis. Indeed, several hierarchical systems for grading evidence state that the results of studies must be consistent or homogeneous to obtain the highest grading.2–4
Tests for heterogeneity are commonly used to decide on methods for combining studies and for concluding consistency or inconsistency of findings.5 6 But what does the test achieve in practice, and how should the resulting P values be interpreted?
A test for heterogeneity examines the null hypothesis that all studies are evaluating the same effect. The usual test statistic …read more
Citations
More filters
Journal ArticleDOI
Impulsivity-related personality traits and adolescent alcohol use: A meta-analytic review
Kaidy Stautz,Andrew Cooper +1 more
TL;DR: Results indicate that excessive alcohol consumption during adolescence may be driven in part by the desire to seek novel and exciting experiences.
Journal ArticleDOI
Quality control and conduct of genome-wide association meta-analyses
Thomas W. Winkler,Felix R. Day,Damien C. Croteau-Chonka,Andrew R. Wood,Adam E. Locke,Reedik Mägi,Teresa Ferreira,Tove Fall,Mariaelisa Graff,Anne E. Justice,Jian'an Luan,Stefan Gustafsson,Joshua C. Randall,Sailaja Vedantam,Tsegaselassie Workalemahu,Tuomas O. Kilpeläinen,André Scherag,Tõnu Esko,Zoltán Kutalik,Iris M. Heid,Ruth J. F. Loos +20 more
TL;DR: In this article, a general protocol for conducting GWAMAs and carrying out QC to minimize errors and to guarantee maximum use of the data is presented. But this protocol is not suitable for large consortia such as the GIANT Consortium.
Journal ArticleDOI
Gender and telomere length : systematic review and meta-analysis
Michael P. Gardner,David Bann,Laura Wiley,Rachel Cooper,Rebecca Hardy,Dorothea Nitsch,Carmen Martin-Ruiz,Paul G. Shiels,Avan Aihie Sayer,Michelangela Barbieri,Sofie Bekaert,Claus Bischoff,Angela Brooks-Wilson,Wei Chen,Cyrus Cooper,Kaare Christensen,Tim De Meyer,Ian J. Deary,Geoff Der,Ana V. Diez Roux,Annette L. Fitzpatrick,Anjum Hajat,Julius Halaschek-Wiener,Sarah E. Harris,Steven C. Hunt,Carol Jagger,Hyo Sung Jeon,Robert C. Kaplan,Masayuki Kimura,Peter M. Lansdorp,Changyong Li,Toyoki Maeda,Massimo Mangino,Tim S. Nawrot,Peter M. Nilsson,Katarina Nordfjäll,Giuseppe Paolisso,Fu Ren,Karl Riabowol,Tony Robertson,Göran Roos,Jan A. Staessen,Tim D. Spector,Nelson L.S. Tang,Brad M. Unryn,Pim van der Harst,Jean Woo,Chao Xing,Mohammad E Yadegarfar,Jae Yong Park,Neal S. Young,Diana Kuh,Thomas von Zglinicki,Yoav Ben-Shlomo +53 more
TL;DR: Telomere length is longer in females than males, although this difference was not universally found in studies that did not use Southern blot methods, and further research on explanations for the methodological differences is required.
Journal ArticleDOI
Nonsteroidal anti‐inflammatory drugs for dysmenorrhoea
TL;DR: Among women with primary dysmenorrhoea, NSAIDs were more effective for pain relief than placebo, and there was little evidence of the superiority of any individual NSAID for either pain relief or safety.
Journal ArticleDOI
Mindfulness‐ and acceptance‐based interventions for anxiety disorders: A systematic review and meta‐analysis
TL;DR: MABIs are associated with robust and substantial reductions in symptoms of anxiety and comorbid depressive symptoms, and differential effect sizes indicated benefits of adding specific psychotherapeutic content to mindfulness training, as well as an advantage of individual over group treatment.
References
More filters
Journal ArticleDOI
Quantifying heterogeneity in a meta‐analysis
TL;DR: It is concluded that H and I2, which can usually be calculated for published meta-analyses, are particularly useful summaries of the impact of heterogeneity, and one or both should be presented in publishedMeta-an analyses in preference to the test for heterogeneity.
Journal ArticleDOI
The combination of estimates from different experiments.
TL;DR: The problem of making a combined estimate has been discussed previously by Cochran and Yates and Cochran (1937) for agricultural experiments, and by Bliss (1952) for bioassays in different laboratories as discussed by the authors.
Journal ArticleDOI
Tamoxifen for early breast cancer: An overview of the randomised trials
TL;DR: The absolute improvement in recurrence was greater during the first 5 years, whereas the improvement in survival grew steadily larger throughout the first 10 years, and these benefits appeared to be largely irrespective of age, menopausal status, daily tamoxifen dose, and of whether chemotherapy had been given to both groups.
Journal Article
Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group
TL;DR: There have been many randomised trials of adjuvant tamoxifen among women with early breast cancer, and an updated overview of their results is presented in this paper, which approximately doubles the amount of evidence from trials of about 5 years of tamoxifier and, taking all trials together, on events occurring more than 5 years after randomisation.
Journal ArticleDOI
Funnel plots for detecting bias in meta-analysis: guidelines on choice of axis.
TL;DR: In this paper, the authors evaluated standard error, precision (inverse of standard error), variance, inverse of variance, sample size and log sample size (vertical axis) and log odds ratio, log risk ratio and risk difference (horizontal axis).